vatalanib

mechanistic target of rapamycin kinase ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24685058 A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma. 2014 Aug 1
2 20404549 Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivo. 2010 Jun 1 1